Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

Item
http://www.wikidata.org/entity/Q24247924
Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancerIntravesical electromotive drug administration for non-muscle invasive bladder cancerIntravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancerIntravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancerIntravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancerIntravesical therapy for non-muscle invasive bladder cancer: a network meta-analysisBacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literatureGSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy.Provider treatment intensity and outcomes for patients with early-stage bladder cancer.Emerging intravesical therapies for management of nonmuscle invasive bladder cancerNew therapeutic targets in the management of urothelial carcinoma of the bladderAntitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer.Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.Intravesical electromotive drug administration for non-muscle invasive bladder cancer.Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy.The efficacy and safety of intravesical gemcitabine vs Bacille Calmette-Guérin for adjuvant treatment of non-muscle invasive bladder cancer: a meta-analysis
P2860

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

Item
http://www.wikidata.org/entity/Q24247924
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@ast
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@en
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@en-gb
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@nl
type
label
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@ast
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@en
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@en-gb
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@nl
prefLabel
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@ast
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@en
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@en-gb
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@nl
P1433
P1476
P2093
P2860
P31
P356
P577
P698
P356
P1433
P1476
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
@en
P2093
P2860
P31
P356
P577
P698